Literature DB >> 29850141

Novel biologic factors correlated to visceral pleural invasion in early-stage non-small cell lung cancer less than 3 cm.

Han-Yu Deng1,2, Gang Li1, Jun Luo1, Guha Alai1, Ze-Guo Zhuo1, Yi-Dan Lin1.   

Abstract

BACKGROUND: Visceral pleural invasion (VPI) in early-stage non-small cell lung cancer (NSCLC) is traditionally believed as the result of too much close distance between cancerous lesion and the visceral pleura, but whether there are any other biologic factors correlated to VPI beyond our instinctive thoughts remains unclear. Therefore, we conducted this study to investigate potential factors correlated to VPI comprehensively.
METHODS: Both clinical and pathological characteristics of patients undergoing surgery for NSCLC with a size of ≤3 cm were retrospectively analysed.
RESULTS: A total of 403 patients were included for analysis. Patients with VPI had older age than those without (61.1 vs. 56.1 years; P<0.001). The mean size of NSCLCs with VPI was larger than those without (2.1 vs. 1.6 cm; P<0.001). Moreover, NSCLCs with VPI were located closer to visceral pleura (0.8 vs. 1.3 cm; P<0.001) and showed larger rates of pleural indentation (86.8% vs. 45.6%; P<0.001) and spiculation (59.7% vs. 34.7%; P<0.001) than those without. Pathologically, NSCLCs with VPI tended more likely to be adenocarcinomas (96.9% vs. 92.7%; P=0.097), and was more likely to be poorly differentiated (38.0% vs. 15.3%; P<0.001), to have cancer embolus (6.2% vs. 0.7%; P=0.001) and lymph node metastasis (29.5% vs. 10.2%; P<0.001) than those without. Besides shorter distance to visceral pleura [odds ratio (OR)=2.169, 95% CI: 1.221-3.855; P=0.008], older age [OR =2.119, 95% confidence interval (CI): 1.255-3.503; P=0.005], pleural indentation (OR =3.679, 95% CI: 1.888-7.169; P<0.001), adenocarcinoma (OR =4.741, 95% CI: 1.383-16.255; P=0.013), and poor tumor differentiation (OR =11.816, 95% CI: 4.470-31.234; P<0.001) were also found to be closely correlated to VPI in early-stage NSCLC.
CONCLUSIONS: Besides shorter distance to visceral pleura and pleural indentation, elderly, adenocarcinoma, and poor tumor differentiation were novel biologic factors correlated to VPI in early-stage NSCLC, which may explain why VPI was an unfavorable prognostic factor for early-stage NSCLC.

Entities:  

Keywords:  Non-small cell lung cancer (NSCLC); correlated factors; early stage; pleural invasion

Year:  2018        PMID: 29850141      PMCID: PMC5949454          DOI: 10.21037/jtd.2018.03.185

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  22 in total

Review 1.  Lung cancer.

Authors:  Roy S Herbst; John V Heymach; Scott M Lippman
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

2.  Prognostic impact of pleural invasion in 1488 patients with surgically resected non-small cell lung carcinoma.

Authors:  Mayumi Oyama; Akiko Miyagi Maeshima; Naobumi Tochigi; Koji Tsuta; Riken Kawachi; Hiroyuki Sakurai; Shunichi Watanabe; Hisao Asamura; Hitoshi Tsuda
Journal:  Jpn J Clin Oncol       Date:  2013-03-13       Impact factor: 3.019

3.  Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer.

Authors:  Kimihiro Shimizu; Junji Yoshida; Kanji Nagai; Mitsuyo Nishimura; Genichiro Ishii; Yasuo Morishita; Yutaka Nishiwaki
Journal:  J Thorac Cardiovasc Surg       Date:  2005-07       Impact factor: 5.209

4.  Visceral pleural invasion impacts the prognosis of non-small cell lung cancer: A meta-analysis.

Authors:  Q-X Liu; X-F Deng; D Zhou; J-M Li; J-X Min; J-G Dai
Journal:  Eur J Surg Oncol       Date:  2016-03-30       Impact factor: 4.424

Review 5.  Visceral pleural invasion remains a size-independent prognostic factor in stage I non-small cell lung cancer.

Authors:  He Huang; Ting Wang; Bin Hu; Changchuan Pan
Journal:  Ann Thorac Surg       Date:  2015-02-20       Impact factor: 4.330

6.  Pleural invasion by peripheral lung cancer: prediction with three-dimensional CT.

Authors:  Kiyonori Ebara; Shodayu Takashima; Binghu Jiang; Hodaka Numasaki; Mai Fujino; Yasuhiko Tomita; Katsuyuki Nakanishi; Masahiko Higashiyama
Journal:  Acad Radiol       Date:  2014-12-23       Impact factor: 3.173

7.  RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer.

Authors:  Rui Xing; Kuan-Bing Chen; Ying Xuan; Chi Feng; Ming Xue; Yue-Can Zeng
Journal:  Surg Oncol       Date:  2016-05-10       Impact factor: 3.279

Review 8.  Radiotherapy, lobectomy or sublobar resection? A meta-analysis of the choices for treating stage I non-small-cell lung cancer.

Authors:  Han-Yu Deng; Yun-Cang Wang; Peng-Zhi Ni; Gang Li; Xiao-Yan Yang; Yi-Dan Lin; Lun-Xu Liu
Journal:  Eur J Cardiothorac Surg       Date:  2017-02-01       Impact factor: 4.534

9.  CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis.

Authors:  Pranav Gupta; Praveen K Sharma; Hina Mir; Rajesh Singh; Nalinaksha Singh; Goetz H Kloecker; James W Lillard; Shailesh Singh
Journal:  Oncotarget       Date:  2014-10-30

10.  The predictive and prognostic values of factors associated with visceral pleural involvement in resected lung adenocarcinomas.

Authors:  Huibiao Zhang; Chen Lu; Yingjie Lu; Bo Yu; Fanzhen Lv; Zhenghong Zhu
Journal:  Onco Targets Ther       Date:  2016-04-20       Impact factor: 4.147

View more
  6 in total

1.  Is lobectomy superior to sub-lobectomy in non-small cell lung cancer with pleural invasion? A population-based competing risk analysis.

Authors:  Xue Song; Yangyang Xie; Yurou Zhu; Yafang Lou
Journal:  BMC Cancer       Date:  2022-05-13       Impact factor: 4.638

2.  The Value of 18F-FDG PET/CT in the Diagnosis of Tuberculous Pleurisy and in the Differential Diagnosis between Tuberculous Pleurisy and Pleural Metastasis from Lung Adenocarcinoma.

Authors:  Xiaoqing Du; Feng Zhu; Chunjing Yu
Journal:  Contrast Media Mol Imaging       Date:  2022-07-31       Impact factor: 3.009

3.  Rethinking the Selection of Pathological T-Classification for Non-Small-Cell Lung Cancer in Varying Degrees of Visceral Pleural Invasion: A SEER-Based Study.

Authors:  Pu Fang; Jiayi Cheng; Youjin Lu; Lin Fu
Journal:  Front Surg       Date:  2022-05-19

4.  Early stage lung cancer: pathologist's perspective.

Authors:  Francesca Boggio; Alessandro Del Gobbo; Giorgio Croci; Marco Barella; Stefano Ferrero
Journal:  J Thorac Dis       Date:  2020-06       Impact factor: 3.005

5.  Impact of visceral pleural invasion on the association of extent of lymphadenectomy and survival in stage I non-small cell lung cancer.

Authors:  Yang Wo; Yandong Zhao; Tong Qiu; Shicheng Li; Yuanyong Wang; Tong Lu; Yi Qin; Guisong Song; Shuncheng Miao; Xiao Sun; Ao Liu; Dezhi Kong; Yanting Dong; Xiaoliang Leng; Wenxing Du; Wenjie Jiao
Journal:  Cancer Med       Date:  2019-02-01       Impact factor: 4.452

6.  Sublobectomy versus lobectomy for long-term survival outcomes of early-stage non-small cell lung cancer with a tumor size ≤2 cm accompanied by visceral pleural invasion: a SEER population-based study.

Authors:  Yue Yu; Renhong Huang; Pei Wang; Suyu Wang; Xinyu Ling; Peng Zhang; Jingwen Yu; Jun Wang; Jian Xiao; Zhinong Wang
Journal:  J Thorac Dis       Date:  2020-03       Impact factor: 3.005

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.